HealthCap

HealthCap is a European venture capital firm that invests globally in life sciences, focusing on breakthrough therapies for diseases with high unmet medical needs. They aim to back companies developing therapeutic interventions with the potential to significantly improve patient outcomes, transform clinical practice, and change the lives of patients suffering from these conditions. A cornerstone of their strategy is precision medicine, developing the right medicine for the right patient. HealthCap has substantial experience in helping start-ups and emerging companies grow into businesses ready for initial public offerings or trade sales. HealthCap's investment approach centers on companies developing targeted therapies for rare diseases, cancers, and genetic diseases. They prioritize emerging therapeutics with high unmet medical needs. They actively collaborate with various stakeholders, including investors, the academic community, portfolio companies, patients, and other key players in society. HealthCap believes in fostering the life science ecosystem both locally and globally, contributing to advancements in healthcare and making a positive impact on society. They seek to challenge current medical paradigms to explore new ways of treating or even curing diseases and improving the quality of life. They actively participate in the portfolio companies' development by taking board seats and leveraging their extensive scientific and industrial networks for recruitment. They ensure management receives the relevant support and resources to run the company in an efficient, responsible, and accountable manner, focusing on long-term sustainability.

Life Sciences, Breakthrough Therapies, Rare Diseases, Cancers, Genetic Diseases, Therapeutics, Precision Medicine, Pharmaceuticals, Innovative Medical Devices

Core thematic spaces, technologies, and target market segments of interest.